Document Detail

Management and outcome of pregnancy in autoimmune hepatitis.
MedLine Citation:
PMID:  11115829     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: There is a paucity of data in the literature on the risks associated with, and optimal management of, pregnancy in patients with autoimmune hepatitis (AIH). AIMS: To assess maternal and fetal outcomes in relation to clinical management of pregnancy in a large cohort of patients with well defined AIH. METHODS: A review of all known pregnancies in 162 females with definite AIH attending our clinics between 1983 and 1998, with respect to treatment, natural history, and outcome. RESULTS: Thirty one live births (one twin) resulted from 35 pregnancies in 18 women (seven with cirrhosis). Median age at conception was 28 years (range 18-36). Two patients presented with AIH de novo during pregnancy. At conception, in 15 pregnancies patients had been receiving azathioprine alone or (in nine) with prednisolone, in seven prednisolone alone, and in one cyclosporin. Fetal loss at > or =20 weeks' gestation occurred in two instances. Flares in disease activity occurred during four pregnancies and within three months of delivery in a further four. Among the 31 children born (median follow up 10 years) only two abnormalities have been identified: Perthes' disease in one and severe mental and physical handicap in a second who was born prematurely following decompensation of the mother's liver disease. Neither mother was receiving azathioprine. CONCLUSIONS: Successful completion of pregnancy is a realistic expectation for patients with well controlled AIH. Treatment options vary, but azathioprine appears to be generally safe and without adverse outcomes for mother or baby. Vigilance is required, however, and patients need to be monitored carefully during pregnancy and for several months post partum.
M A Heneghan; S M Norris; J G O'Grady; P M Harrison; I G McFarlane
Related Documents :
15522059 - Recommendations on haematological criteria for the diagnosis of epoetin-induced pure re...
11911619 - Asthma in pregnancy.
7337409 - Eisenmenger complex and pregnancy.
9804089 - Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with ...
18625819 - Effects and treatment of inflammatory bowel disease during pregnancy.
25128169 - Prolonged uterine artery nitric oxide synthase inhibition modestly alters basal uteropl...
24498169 - Promoter dna methylation of farnesoid x receptor and pregnane x receptor modulates the ...
22554179 - The role of vitamin d in pregnancy and lactation: emerging concepts.
11429639 - Hormones and calcium: mechanisms controlling uterine smooth muscle contractile activity...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Gut     Volume:  48     ISSN:  0017-5749     ISO Abbreviation:  Gut     Publication Date:  2001 Jan 
Date Detail:
Created Date:  2001-01-30     Completed Date:  2001-02-22     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  2985108R     Medline TA:  Gut     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  97-102     Citation Subset:  AIM; IM    
Institute of Liver Studies, King's College Hospital, Denmark Hill, London SE5 9RS, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Azathioprine / therapeutic use*
Chi-Square Distribution
Follow-Up Studies
Hepatitis, Autoimmune / mortality,  therapy*
Immunosuppressive Agents / therapeutic use*
Prednisolone / therapeutic use*
Pregnancy Complications / mortality,  therapy*
Pregnancy Outcome
Retrospective Studies
Statistics, Nonparametric
Reg. No./Substance:
0/Immunosuppressive Agents; 446-86-6/Azathioprine; 50-24-8/Prednisolone
Comment In:
Gut. 2001 Jan;48(1):7-8   [PMID:  11115813 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular...
Next Document:  Hepatocellular carcinoma in Central Europe: prognostic features and survival.